YEATS protein potential therapeutic target for cancer
One area of interest focuses on histones, the chief component of chromatin, a cluster of large molecules. …
One area of interest focuses on histones, the chief component of chromatin, a cluster of large molecules. …
MIT researchers have now developed a new way to model the effects of these genetic mutations in mice. Their approach, based on the genome-editing technique known as CRISPR, is much faster than existing strategies, which require genetically engineering mice that carry the cancerous mutations. “It’s a very rapid and very adaptable approach to make models,” says Thales Papagiannakopoulos, a postdoc at MIT’s Koch Institute for Integrative Cancer Research and one of the lead authors of the paper, which appears in the Oct…
Dr Jason Greenwood from Queen’s Centre for Plasma Physics collaborated with academics from Italy and Spain on the work on electrons, which has been published in the international journal Science. Using some of the shortest laser pulses in the world, the researchers used strobe lighting to track the ultra-fast movement of the electrons within a nanometer-sized molecule of amino acid. The resulting oscillations — lasting for 4,300 attoseconds (billion-billionths of a second) — amount to the fastest process ever observed in a biological structure. …
The variant, a difference in just one of the three billion “letters” in the human genome known as a single-nucleotide polymorphism (SNP), originates from indigenous Americans and confers significant protection from breast cancer, particularly the more aggressive estrogen receptor-negative forms of the disease, which generally have a worse prognosis. “The effect is quite significant,” said Elad Ziv, MD, professor of medicine and senior author of the study. “If you have one copy of this variant, which is the case for approximately 20% (the range being 10 to 25 percent) of U.S. …
Mutations in the body’s cells randomly accumulate as part of the aging process, and most are harmless. For some people, genetic changes in blood cells can develop in genes that play roles in initiating leukemia and lymphoma even though such people don’t have the blood cancers, the scientists report Oct…
“This has the potential to dramatically change how we treat cancer,” says Dr. Pramod Srivastava, director of the Carole and Ray Neag Comprehensive Cancer Center at UConn Health and one of the principal investigators on the study. “This research will serve as the basis for the first ever genomics-driven personalized medicine clinical trial in immunotherapy of ovarian cancer, and will begin at UConn Health this fall,” Srivastava says. UConn bioinformatics engineer Ion Mandoiu, associate professor of computer science and engineering, collaborated as the other principal investigator for the study, which has been in development for the past four years…
The key to the advance is a new invention, called the SunTag, a series of molecular hooks for hanging multiple copies of biologically active molecules onto a single protein scaffold used to target genes or other molecules. Compared to molecules assembled without these hooks, those incorporating the SunTag can greatly amplify biological activity. …
“This drug delivery system is DNA-based, which means it is biocompatible and less toxic to patients than systems that use synthetic materials,” says Dr. Zhen Gu, senior author of a paper on the work and an assistant professor in the joint biomedical engineering program at NC State and UNC Chapel Hill. …
Mutations in the gene that encodes BRCA2 are well known for raising the risk of breast cancer and other cancers. Although the protein was known to be involved in DNA repair, its shape and mechanism have been unclear, making it impossible to target with therapies. …
Sonic Hedgehog belongs to a family of proteins that gives cells the information needed for the embryo to develop properly. It also plays a significant role in tumorigenesis, the process that transforms normal cells into cancer cells…